SCIESCOPUSQ1
Cancer Immunology Research
AMER ASSOC CANCER RESEARCH, United States
Cancer Immunology Research is an academic journal published by AMER ASSOC CANCER RESEARCH (United States). Identifiers: ISSN 2326-6066, eISSN 2326-6074. Indexed in SCIE, SCOPUS. Metrics: JIF 8.2, CiteScore 12.8, SJR 3.630, SNIP 1.27. Subject areas: IMMUNOLOGY, ONCOLOGY. tlooto lists 4,302 papers from this journal.
CiteScore
12.80
Scopus citation metric
SJR
3.630
SCImago rank
SNIP
1.27
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 2326-6066
- eISSN
- 2326-6074
- Abbreviation
- CANCER IMMUNOL RES
- Publisher
- AMER ASSOC CANCER RESEARCH
- Country
- United States
Web of Science categories
SCIEIMMUNOLOGY, ONCOLOGY
Scopus ASJC categories
1306 Cancer Research2403 Immunology
Keywords
Oncology | Immunology
Papers in this journal
Recent papers
- Abstract A020: Novel natural killer cell therapy using unique NK cell subset
2026
- Abstract C034: Epithelial alarmins coordinate type 2 immunity in colorectal cancer
2026
- CCL1-AMFR facilitates glioblastoma progression by modulating the crosstalk between glioma cells and tumor-associated macrophages.
2026
- Abstract A006: Clonal dynamics of tumor-infiltrating CD4+ T cells in response to immune checkpoint and Shp-1 inhibition
2026
- Abstract LB-C009: Tumor methylation subtypes predict the clinical outcome to immunotherapy in pleural mesothelioma patients from the NIBIT-EPI-MESO study
2026
Most cited papers
- PD-L1 Expression in Triple Negative Breast Cancer
2014 · 1,161 citations
- NF-κB, an Active Player in Human Cancers
2014 · 977 citations
- Myeloid-derived suppressor cells
2017 · 949 citations
- Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells
2013 · 800 citations
- Mesothelin-specific Chimeric Antigen Receptor mRNA-Engineered T cells Induce Anti-Tumor Activity in Solid Malignancies
2013 · 798 citations